Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
FTSE 100
7,607.28
(
1.56%
)
Dow Jones
33,762.76
(
2.12%
)
Gold vs US Dollar
1,948.195
(
-1.46%
)
Brent Oil
76.235
(
2.57%
)
Bitcoin
27,252.97
(
1.61%
)
 

LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Polarean Imaging Plc (POLX)

  7. Polarean Imaging Plc (POLX) Share Price

POLX

Polarean Imaging Plc

26.00
1.50 (6.12%)
Upgrade to Real-Time
Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Shares Traded Last Trade
Upgrade Icon
  1.50 6.12% 26.00 2,377,767 16:35:16
Bid Price Offer Price High Price Low Price Open Price
26.00 28.00 29.00 22.00 24.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Surgical,med Instr,apparatus 1.19 -14.02 -6.70 - 54.38
Last Trade Time Trade Type Trade Size Trade Price Currency
16:36:42 O 250,000 27.00 GBX
Related Shares
Astrazeneca (AZN), Gsk (GSK), Fusion Antibodies (FAB), Yourgene Health (YGEN)

Polarean Imaging (POLX) Latest News (4)

Polarean Imaging News

Date Time Source Headline
02/6/202319:35ALNCNewsPolarean shares jump after unveiling collaboration with Philips
02/6/202315:00UKREGPolarean Imaging PLC Collaboration with Philips at ISMRM 2023
02/6/202307:00UKREGPolarean Imaging PLC Extension of Warrants
26/5/202310:51ALNCNewsPolarean shares down despite narrowed annual loss and optimism
26/5/202307:00UKREGPolarean Imaging PLC Final Results
11/5/202314:42UKREGPolarean Imaging PLC First clinical scan using XENOVIEW in Cincinnati
03/5/202317:00RNSNONPolarean Imaging PLC Featured at 2023 ATS Respiratory Innovation Summit
26/4/202316:52ALNCNewsTRADING UPDATES: Capital Metals to appeal Sri Lanka mining suspension
26/4/202307:00UKREGPolarean Imaging PLC First order for XENOVIEW gas blend received
17/4/202307:00UKREGPolarean Imaging PLC Appointment of Dan Brague as consultant

Polarean Imaging (POLX) Discussions and Chat

Polarean Imaging Forums and Chat

Date Time Title Posts
02/6/202319:45Polarean Imaging PLC4,023

Add a New Thread

Polarean Imaging (POLX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:36:4327.00250,00067,500.00O
16:00:3927.50100,00027,500.00O
15:35:1626.004,1851,088.10UT
15:35:0026.007720.02O
15:29:1726.801,274341.43O

Polarean Imaging (POLX) Top Chat Posts

Top Posts
Posted at 02/6/2023 17:56 by ppmm
Possibly a lack of focus on initiating immediate sales, which management and the share price have suffered for is as a result of a focus on much bigger developments.

The extension in time on the warrants - is to reflect that he's not been able to convert them because he's party to price sensitive info information which precludes him from exercising them. Says to me big newsfliw is anticipated soonish.
Read Full Thread
Follow
Reply
Posted at 02/6/2023 12:55 by goldbutler
Polx share price 22.0p

The AGM should have been held in a UK location this year

This is very poor from the company and their nomad.
Read Full Thread
Follow
Reply
Posted at 02/6/2023 12:24 by goldbutler
POLX share price 22.5p

would it make any difference if the chairman bought via warrants in june or july -No

But that is not the issue here .
This is another own goal and Walbrook PR are not to blame.

Failure to disclose warrant ex price is just wrong from corporate governance and just simple decent behaviour.

Where are the Indep directors.

Shareholders interests are in the rear view mirror here.
10 YEARS to arrange conversion and Ind Directors should have stepped up to the mark and said NO.

Stifel the ultra woke outfit can celebrate every "event" from thanksgiving to Saint Valentines day they even drop "saint" and beyond , on twitter , - with the exception of Christmas which they ignore , should be removed and replaced. It is a surprise that they even use the calendar date 2023.

Stifel advice to the company seemingly leaked and categorically referred to by Amati as ill-considered fund raise are very poor.

Voting papers are out for the AGM and shareholders have the opportunity of notifying the company that they own the company and vote accordingly.

Non executive directors have a role to play - and it is not to sign for their cheques and do nothing.

AMATI VCT have a new video out and they continue to engage with the company.
They and other large and small shareholders need to vote.
Read Full Thread
Follow
Reply
Posted at 24/3/2023 15:36 by goldbutler
Polx share price 21p

Thanks for the knowhow tip raddersSandy - never too old to learn

Commercial opportunity here on Covid alone is immense.

Other hospital clinical equipment even CT
cannot detect what Polarean xenoview is able to show.

Explain study via Prof Gleeson and his associates have repeated that with Polarean's equipment they can see what is unable to be shown on other equipment.

Within the next 8 months Polarean has a form filling exercise for UK approval.

The commercial opportunity is here.

There are European countries some with huge populations , some smaller.
There is a European wide opportunity for Long Covid scanning.

Polarean have enough cash to may 2024 and have stated they are looking to sign up
with corporate partners
Read Full Thread
Follow
Reply
Posted at 27/2/2023 16:57 by hedgehog 100
purchaseatthetop 25 Feb '23 - 07:32 - 3630 of 3644 0 1 0
"Pug ugly. Quite correct. However it is UK company owned technology and the USA has huge barriers to entry. Basically it is largely a closed shop. Devices have huge problems compared to medicines. And it is tough for medicines! Lesson from this is always sell on the news."

amaretto1 25 Feb '23 - 12:56 - 3634 of 3644 0 1 0
"No hes basically outlining what happens to ALL companies trying to break in to the USA ....
EG ... AGL .... STX ... two examples of many !
AGL is a mirror image of POLX even down to share price movement and mkt cap.
AGL are further down the road and have 3 X cash of POLX.
A wise man/woman would split the risk ....."


I would agree that achieving big success in America from over here isn't that easy or common.

But it does sometimes happen, and the rewards when it does can be very great.

Here are a couple of historic examples:-

1. Hanson

"A company from here doing rather well over there."
http://news.bbc.co.uk/1/hi/business/3973543.stm

2. Reebok

American sales were key to the success of British 150-bagger Pentland Industries, which sold Reebok into the US through its US subsidiary Reebok USA Ltd.

" ... In 1987, Reebok’s sales totalled $1.4 billion—a thousand times what Fireman first generated in 1981. By 1988, that number had grown to $1.8 billion, with Reebok controlling 26.7 percent of the athletic footwear market and besting Nike’s $1.2 billion in revenue. ... "
HTTP://www.grailed.com/drycleanonly/reebok-history


And in recent years, UK minnow Newmark Security (NWT) has expanded very successfully 'across the pond', although this isn't yet well known.

From NWT's new annual report & accounts, the bar graph on page 12:-

"Five years of consecutive revenue growth:
HCM in North America: £m"

2017: £0.9M.
2018: £1.2M.
2019: £4.0M.
2020: £5.9M.
2021: £6.5M.
2022: £8.7M.

HTTP://newmarksecurity.com/assets/Newmark-Annual-Report-30-April-2022.pdf

HTTP://newmarksecurity.com/investor-relations/reports-and-presentations/
Read Full Thread
Follow
Reply
Posted at 21/2/2023 06:10 by fft
Bracco has a turnover of about 1.7bn euros. Private company so not easy to value.If the institutions were given the same treatment as the PI's I can see why the placing didn't happen. The institutions could have suggested 30p not 40p which presumably the company didn't like.POLX now has a market cap of less than 70m GBP. At 20p it would be about 45m GBP. If Bracco wanted to take out POLX.they would need to come in with a premium to get the institutions onside. Say 40p :-). But I don't see that. Doesn't make sense for Bracco because that could lead to an alternative bid which would be messy for Bracco. Fees are also quite high. I wouldn't be surprised to see a convertible loan from Bracco. Say 10-15m GBP with the option to convert, whenever they like, at say 25-30p. If they think POLX would fit into the Bracco portfolio and they are confident about POLX they could try to max it out to a 29% shareholding in POLX which would enable a fairly easy takeover in 5-10 years time. Quite a cheap low risk strategy. If POLX doesn't deliver, they don't convert, demand the money back and, because POLX won't have the cash get the assets, intellectual property etc.Just thinking aloud.
Read Full Thread
Follow
Reply
Posted at 14/2/2023 11:00 by wetdream
The sp’s in the control of the BOTs - probably selling early then buying later in the day.
No reported shorts in place - anyway, anyone wanting to short the stock could trash the share price - but no, just enough volume to pressure the share price downwards.
Problem is that there’s no obvious value for the company at the moment.
Looking back, market sentiment seems to have been worth c.50p a share!
Funny old world, innit?!
Read Full Thread
Follow
Reply
Posted at 02/2/2023 07:06 by seball
Courtesy of Telegraph Questor column in Feb 2021:

Should authorisation be granted, the financial as well as medical benefits should quickly be visible. Boxall said Polarean was already talking to hospitals with a view to making sales quickly. “It shouldnâ€͐2;t be difficult to sell,â€�; he said. It helps that Polareanâ€T82;s kit is relatively inexpensive next to the cost of the MRI scanner itself.

Spencer-Walsh added: “Itâ364;™s obviously loss-making at the moment. Its broker forecasts profitability by 2025, then $167m (£119m) of sales in 2030 and profits of $60m. It expects 40pc annual growth in the early years, then 30pc by 2028-29. But it will be bought by then, possibly by Bracco Imaging of Italy, one of its biggest shareholders.

“My biggest fear is that it will be bought too soon. Depending on timing, it could fetch £500m-£1bn, against £194m now.â€�

Questor says: speculative buy
Ticker: POLX
Share price at close: 93p

So, a few points to note:
1. We now have authorisation.
2. Our share price is now HALF what it was 2 years ago. In other words, you can buy 'em on a 2 for 1 basis just now.
3. Approx 10p per share is cash.
4. We will probably be bought out at some point within the next 5 years.
Read Full Thread
Follow
Reply
Posted at 19/1/2023 09:23 by seball
From poster on LSE and why I'm invested.

Courtesy of Telegraph Questor column in Feb 2021:

Should authorisation be granted, the financial as well as medical benefits should quickly be visible. Boxall said Polarean was already talking to hospitals with a view to making sales quickly. “It shouldn’t be difficult to sell,” he said. It helps that Polarean’s kit is relatively inexpensive next to the cost of the MRI scanner itself.

Spencer-Walsh added: “It’s obviously loss-making at the moment. Its broker forecasts profitability by 2025, then $167m (£119m) of sales in 2030 and profits of $60m. It expects 40pc annual growth in the early years, then 30pc by 2028-29. But it will be bought by then, possibly by Bracco Imaging of Italy, one of its biggest shareholders.

“My biggest fear is that it will be bought too soon. Depending on timing, it could fetch £500m-£1bn, against £194m now.”

Questor says: speculative buy
Ticker: POLX
Share price at close: 93p

So, a few points to note:
1. We now have authorisation.
2. Our share price is now HALF what it was 2 years ago. In other words, you can buy 'em on a 2 for 1 basis just now.
3. Approx 10p per share is cash.
4. We will probably be bought out at some point within the next 5 years.
Read Full Thread
Follow
Reply
Posted at 11/1/2023 09:57 by seball
Sellers now drying up. Any buys coming in now and POLX Share price will rerate as shares are in tight supply. This is ridiculously undervalued Buy
Read Full Thread
Follow
Reply
Polarean Imaging share price data is direct from the London Stock Exchange
Your Recent History
LSE
POLX
Polarean I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230602 23:19:41